STEPHEN MARDER: Open Payments
NPI 1063437762 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 4 payments from 4 companies in 2025. Trend: 2023 $12,734 · 2024 $28,617 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $112 |
| Neurocrine BioSciences, Inc. | 1 | $39 |
| ABBVIE INC. | 1 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: COBENFY, CAPLYTA.
Industry payments across CA — which companies pay providers there.
